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Abstract: Asthma prevalence in children and adolescents in Spain is 10-17%. It is the most common chronic illness 
during childhood. Prevalence has been increasing over the last 40 years and there is considerable evidence that, among 
other factors, continued exposure to cigarette smoke results in asthma in children. No statistical or simulation model 
exist to forecast the evolution of childhood asthma in Europe. Such a model needs to incorporate the main risk factors 
that can be managed by medical authorities, such as tobacco (OR = 1.44), to establish how they affect the present 
generation of children. A simulation model using conditional probability and discrete event simulation for childhood 
asthma was developed and validated by simulating realistic scenario. The parameters used for the model (input data) 
were those found in the bibliography, especially those related to the incidence of smoking in Spain. We also used data 
from a panel of experts from the Hospital del Mar (Barcelona) related to actual evolution and asthma phenotypes. The 
results obtained from the simulation established a threshold of a 15-20% smoking population for a reduction in the 
prevalence of asthma. This is still far from the current level in Spain, where 24% of people smoke. We conclude that 
more effort must be made to combat smoking and other childhood asthma risk factors, in order to significantly reduce the 
number of cases. Once completed, this simulation methodology can realistically be used to forecast the evolution of 
childhood asthma as a function of variation in different risk factors. 
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1. INTRODUCTION 
Asthma, which affects between 10% and 17% of 
children and adolescents in Spain [1], especially in 
cities, is a chronic inflammatory alteration of the airway 
with consequent narrowing of the bronchial conducts, 
leading to a feeling of breathlessness, coughing and 
difficulty breathing. It has become the leading cause of 
consultation in emergency hospitals and primary health 
centres in Spain at state level. The prevalence of 
childhood asthma makes this disease the most 
common chronic condition in childhood and 
adolescence, therefore it is essential to predict its 
future evolution. 
Childhood asthma has still not been well defined 
and demarcated, which makes it difficult to study its 
epidemiology, diagnosis and treatment. Among 
doctors, doubt has always existed in establishing the 
diagnosis of bronchial asthma in a child who has 
bronchial obstructive episodes. 
In Spain, there are no data on the evolution of the 
prevalence of asthma in children. However, it is 
considered that, as in surrounding countries, the  
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prevalence must be rising [2]. Ten per cent mean 
prevalence of childhood asthma has been observed in 
western countries, but there is great variability among 
countries. This prevalence appears to have been 
increasing over the last 30-40 years, although there is 
debate on whether this is a real increase in prevalence 
or whether an increasing number of children are being 
diagnosed with asthma. Asthma is the leading cause of 
hospitalization in children and the leading cause of 
school absenteeism due to chronic illness. 
Currently, there is no doubt that asthma is 
genetically determined. Its mode of transmission 
(inheritance) is polygenic (several genes on several 
chromosomes), which explains why children of parents 
with asthma may or may not have asthma and that 
among those who have the condition the severity and 
presentation varies [3-5]. 
Nevertheless, the temporary nature of this 
phenomenon (the rapid rise in incidence and the 
differences in prevalence in countries with similar 
genes) indicate that environmental causes are 
important risk factors. Several such factors have been 
proposed to explain asthma: the frequency and 
intensity of viral and bacterial infections, vaccinations 
or exposure to pollutants and allergens inside and 
outside homes, including NO2 and passive smoking. To 
date, the role of each of these factors has not been 
clearly identified, as most research has involved cross-
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sectional studies whose basic subjects were selected 
on the basis of risk factors, such as allergies or asthma 
in adults. Figure 1 presents a summary of the different 
risk factors implicated in the onset and progression of 
asthma in children from birth to adulthood [5]. 
There is considerable evidence that continuing 
exposure to cigarette smoke results in the induction of 
asthma in children. Two large cross-sectional studies in 
the USA involving a total of about 8,000 children and 
adolescents resulted in odds ratios (OR) of 
approximately two for the presence of asthma with 
parental smoking [6] or maternal smoking of more than 
10 cigarettes a day [7]. In a longitudinal investigation of 
asthma incidence among 774 children up to 5 years of 
age at entry, Martínez et al. [8] reported a relative risk 
of 2.5 (95% CI = 1.4-4.6) when maternal smoking 
exceeded 10 cigarettes/day and the mother had at 
most a high-school education. The US EPA, see [9], 
and other studies reviewed this research and stated 
that the evidence leads to the conclusion that 
environmental tobacco smoke (ETS) is a risk factor for 
inducing new cases of asthma. The evidence is 
suggestive of a causal association, but is not 
conclusive [10]. The association of exposure to ETS 
with childhood asthma was examined in different 
studies, concluding that exposure to ETS is associated 
with wheezing symptoms, medical therapy for 
wheezing and wheezing-related emergency 
department visits in US and Canadian children [11]. 
Tobacco is the leading cause of preventable death 
in developed countries and also the most significant 
cause of years of life lost prematurely and years lived 
with disability in Spain [12]. Smoking prevention and 
the fight against tobacco consumption are primary 
objectives of health policies in the international 
community and consequently in Europe and Spain. 
There is continuous implementation of smoke-free 
legislation and information campaigns against smoking, 
particularly in relation to Spanish law 28/2005. A 
decreasing exposure to ETS has been observed in the 
last 10 years and the benefits to the population are 
well-known and have been studied in other 
neighbouring countries such as Italy [13]. This study is 
interested in how smoke-free policy can be an effective 
strategy for reducing childhood asthma in the next 
generation. In particular, tobacco control through 
legislation in Spain in 2008 for promoting a smoke free 
environment is a recommended strategy for reducing 
the prevalence of smoking and consequently ETS in 
the community. 
 
Figure 1: Risk factors implicated in the onset and progression of asthma in children from birth to adulthood (see [5]) from Díaz-
Vazquez (2005). 
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The Spanish anti-tobacco law 28/2005, of 
December 26, came into force on January 1, 2006, 
although some aspects of this act did not come into 
effect until September 2006 and January 2007. The 
most important measure in this law is the ban on 
smoking in places such as workplaces (both public and 
private) or cultural centres. 
According to the Spanish National Health Survey 
[14], and despite the law 28/2005 which came into 
force in 2006, Spain has the highest prevalence rates 
for smoking in the European Community, with 29.5% of 
smokers (26.4% daily: 31.6% of men and 21.5% of 
women were smokers) in 2006 among the population 
over 16 years and only a 1 % reduction between 2003 
and 2007, due to the previous law [14-18]. Other 
studies [19] indicate that the prevalence in daily 
consumption of tobacco among the population aged 15 
to 64 was 32.9%, 32.9% and 35.1 % in 1997, 1999 and 
2001 respectively. The percentage of people who 
smoke in Spain had dropped to 23.7% by early 2007, 
almost a year after the anti-smoking law came into 
force, according to the latest barometer published by 
the Spanish Centre for Sociological Research (CIS) 
[20]. 
The average prevalence across Europe is 28.6% 
(40% men and 18.2% women) [12]. 
Furthermore, there are no statistical and/or 
simulation models that can be used to forecast the 
evolution of the prevalence of childhood asthma in the 
European context. Such models should incorporate the 
main risk factors, such as ETS. The bibliography only 
contains the work of Balemans et al. [21] on prediciting 
asthma in young adults using childhood characteristics 
and the development of a prediction rule using 
multivariate statistics. 
The aim of this study was to create a discrete event 
simulation (DES) model which would reproduce the 
current situation of child asthma in Spain, in order to 
reproduce this pattern from birth to adolescence. This 
model included tobacco, one of the main risks factors 
for asthma, so as to be able to forecast the likelihood of 
the illness in the future as a function of ETS and to 
examine how asthma prevalence is affected by 
different levels of parental tobacco prevalence that 
have been decreasing in Spain in recent years. The 
consequences of parents’ smoke on childhood asthma 
were also discussed. This model includes a 
probabilistic interrelation between the disease and the 
risk factor. It also reproduces the distribution of 
asthma-related episodes of wheezing, and considers 
the phenotype distribution in the time horizon. 
2. METHODS 
2.1. Simulation Models in Epidemiology 
Data found in the bibliography were used as 
parameters of the model (inputs). In addition, data from 
a panel of experts in a hospital in Barcelona were used. 
The model input was as follows: 1) childhood asthma 
prevalence reported in the bibliography (10-17% in 
Spain); 2) level of ETS or parental tobacco prevalence 
as a risk of asthma, using + OR = 1.44 (95% CI 1.27-
1.64) (see [10]) or OR = 2 [6, 7]; parental smoking 
prevalence (%) among the Spanish population, 
reviewed several years before the application of the 
2005 Spanish anti-tobacco law up to now (the last date 
was in 2007) [20]. 
The studies offer different values of asthma risk 
(OR), on the basis of tobacco. Primarily, the ETS and 
prevalence of habitual consumption of tobacco by 
parents was considered. As it is easier to use the 
prevalence of tobacco consumed (daily consumption), 
this was taken as the main risk factor in the model. The 
time horizon of the model was 11 years. 
2.2. Probabilistic Basis of the Model: OR and Risk 
Ratio as Conditional Probability 
To examine the implications of smoking as a risk 
factor in the development of childhood asthma in a 
given population, we need to plan a simulation study. 
After selecting a sample of subjects, the likelihood of 
developing the disease in the study population is P(D). 
The probability of D, P(D) is increased if the risk factor 
(F) is presented with probability P(F), until reaching the 
conditional probability P(D / F ) . If the risk factor is not 
present, the probability is P(D/ F ).  P(D / F ) ,  P(D/ F ) 
and 
 
P(D? F )  were not reported in the bibliography for 
the Spanish population. 
In epidemiology, the association between a risk 
factor or protective factor (exposure) and a disease 
may be evaluated by the “risk ratio” (RR) or the “odds 
ratio” (OR). Both are measures of “relative risk”, the 
general concept of comparing disease risks in exposed 
vs. unexposed individuals [22-24]. The odds ratio (OR) 
is a measure of effect size which allows the prevalence 
of the disease to be linked with the conditional 
probability of the disease and the factor. OR is defined 
as a combination of conditional probabilities, 
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OR =
P(F / D)P(F / D)
P(F / D)P(F / D)
          (1) 
The total population studied (n=a+b+c+d) and the 
relation between disease events and factor presence 
can be represented in a DxF 2 by 2 table, as follows: 
  F   F   
D  a b a+b 
D  c d c+d 
 a+c  b+d n=(a+b+c+d) 
Where: 
 
P(D) =
a + b
n
 , is the marginal probability of disease  (2) 
 
P(D) =
c + d
n
, is the marginal probability of non- 
disease            (3) 
P(F ) =
a + c
n
, is the marginal probability of exposed 
subjects           (4) 
 
P(F ) =
b+ d
n
, is the marginal probability of unexposed 
subjects           (5) 
 
P(D? F ) = a
n
 is the associated probability of disease 
and risk factor           (6) 
OR can be defined as: 
 
OR =
ad
bc
,           (7) 
Where  a / c  are the exposed subjects’ odds of 
acquiring the disease and  b / d  are the unexposed 
populations’ odds of acquiring the disease. An odds 
ratio of 1 implies that the event is equally likely in both 
groups. An OR greater than one implies that the event 
is more likely in the first group P(D/F)>P(D). An OR of 
less than one implies that the event is less likely in the 
first group P(F/D)<(PD). 
On the other hand, using conditional probability 
theorem: 
 
P(D / F ) =
P(D? F )
P(F )
          (8) 
Where P(D? F ) corresponds to the probability 
associated with D and presents the risk factor F. This 
allows us to calculate the conditional probability of 
interest P(D / F ),P(D / F ) . 
 
P(D? F )  corresponds to 
a
n
 in the previous risk DxF 2 by 2 table. 
However, the calculation of 
 
P(D / F ), P(D / F )  using 
(7) is not possible if only one of the following are 
known: P(D) =
a + b
n
 as the prevalence of D (10-17% in 
this study), P(F ) =
a + c
n
 as the prevalence of the risk 
factor (25-35%, in this study) in the population and OR 
(1.4 or 2 in this study).  
 
Figure 2: Probabilistic empirical functions
 
Z
1
= P(D / F ) ? f (P(D), P(F ),OR)  for OR = 1.4 (left) and OR=2 (right) under the 
restriction of disease prevalence in the Spanish population (
 
P(D) = 0.1? 0.17 ); prevalence of smoking (
 
P(F ) = 0.1? 0.4 ) and risk 
relationship between asthma and tobacco, as OR=1.4 or 2, using a simulation algorithm in R. 
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P(D / F ), P(D / F ) can be numerically calculated 
using a simulation of 3 uniform random variables 
 
y
1
?U (1,10000), y
2
?U (1,10000), y
3
?U (1,10000)  to 
generate 2 ?106  values in order to obtain a, b, d values 
under the restriction outlined in the previous 2 by 2 
table (Disease x risk) and (2), (3), (4), (5), (7), 
 
P(D) = 0.1? 0.17 , 
 
P(F ) = 0.1? 0.4  and OR=1.4 and 2. 
This algorithm was developed in R and the different 
approximations to 
 
P(D / F ), P(D / F )  were obtained as 
probabilistic empirical functions 
 
Z
1
= P(D / F ) ? , 
 
f (P(D), P(F ),OR)  
 
Z
2
= P(D / F ) ? f (P(D), P(F ),OR) . 
The results of Z1 are shown in Figure 2, where they are 
represented for OR = 1.4 and OR=2. The error (?) 
between the values of P(D) and P(F) is shown where ? 
?  0.005. The maximum of all the values of P(D/F) 
have been selected. 
Finally, we consider that the event asthma (D) in the 
simulated population depends on a Bernoulli 
distribution of probabilities [
 
y* ? Be(Z1)  if F = 
1, y* ? Be(Z 2 )  if F=0], with a conditional probability of 
the risk factor, tobacco (F), as P(D/F). 
2.3. Phenotype Sub-Model and Wheezing Time 
Event Distribution: Discrete Event Simulation (DES) 
The discrete event simulation (DES) paradigm 
[25,26] was used to construct the simulation model. 
DES is one way of building models to observe the time-
based (or dynamic) behaviour of a system, based on a 
probabilistic model using random variables of a disease 
associated with a risk factor. In DES, the operation of a 
system is represented as a chronological sequence of 
probabilistic events (asthma [D] or wheezing event [W] 
in the present study, associated with risk event [F]). 
Each event occurs at an instant in time and marks a 
change of state in the system. If a paediatric asthma 
episode is simulated, an event could be D, according to 
a Bernoulli distribution of probabilities, or W according 
to a Weibull time distribution of probabilities, 
 
t ?We(? ,?) . 
Moreover, the simulation model has taken into 
account that a child with asthma (D) may have an 
average of 5 episodes of wheezing (W) per year. 
Asthma is considered as 3 or more episodes of 
breathlessness and wheezing per year. Thus, in the 
simulation model we considered, 
 
r
1 ? (N (5,3)  If D=1 (presence of disease)       (9) 
Where (N (5,3)  is the Normal Gaussian distribution 
with an average of 5 W episodes, a standard deviation 
of 3 and positive truncation of values. 
r
2 ?U (0,2)  If D=0 (absence of disease)      (10) 
Where U(0,2) is the uniform distribution with 0 and 2 
W episodes. 
In addition, there was a constant risk (OR) in the 
incidence of smoking on the various phenotypes of 
asthma, supposing a prevalence of 80, 15 and 5% for 
transient wheezing (Phenotype 1), wheezing / non 
atopy (Phenotype 2) and wheezing / atopy phenotypes 
(Phenotype 3) respectively. To increase the sensitivity 
of results and compare the disparity of OR in the 
bibliography, OR = 1.4 and 2 were used. Thus, in the 
simulation model we considered, 
 
t
1
?We(?
1
,?
2
)  if phenotype = 1       (11) 
t
2
?We(?
2
,?
3
)  if phenotype = 2       (12) 
t
3
?We(?
3
,?
3
)  if phenotype = 3       (13) 
Where t1, t2 and t3 are random variables allowing 
different W episodes associated with D to be generated 
as a function of phenotype. 
t1, t2 and t3 were adjusted empirically using the 
median of values for 3, 5 and 10 years old, truncated to 
11 years old, for simulated wheezing episodes (W) in 
the three phenotypes contemplated. A synthesis of the 
DES results is presented in Figure 3, which includes D, 
F, P(D / F), W, t, r and phenotypes. 
We used simulation to generate 10,000 individuals 
and 500 replicae of each simulation scenario. This 
series of simulation scenario was created to study the 
consequences of tobacco exposure on future levels of 
childhood asthma, as well as to make the model 
sensitive and robust. Replicas of simulation were 
generated for each experiment and 95% of the value of 
the prevalence of asthma were calculated among the 
simulated individuals. 
The simulations to obtain 
 
Z
1
= P(D / F )
??  
 
f (P(D), P(F ),OR) , 
 
Z
2
= P(D / F )
?? f (P(D), P(F ),OR)  
were carried out in R and the simulation of the DES 
model was performed with SAS v.9.1 (SAS Institute 
Inc.) and R v. 2.1.0 (R Development Core Team). 
3. RESULTS 
A DES simulation model for childhood asthma was 
validated with respect to data in the bibliography, with a 
prevalence of asthma of around 10% to 17%, based on 
published studies [1, 3, 5, 14]. The results of 14 
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different simulation scenario with 10,000 simulated 
children and 100 replications of each scenario are 
presented in Table 1. 
The scenario reflects the behaviour of the 
prevalence of child asthma and allow it to be observed 
throughout childhood and for different phenotypes. The 
results also indicate the following: a rise in daily 
tobacco consumption, from 32.9% in 1997 to 35.1% in 
2001; a reduction of 5-10% of daily smokers in Spain 
(from 35.1% in 2001 to 26.4% in 2006, during the first 
application of Spanish law 28/2005); and a reduction of 
23.7% in 2007 after complete application of Spanish 
law 28/2005. We also carried out simulations for 
scenario of 20, 15 and 10% asthma prevalence. Each 
value of tobacco prevalence was taken into account for 
OR = 1.4 and OR = 2. 
The rows of Table 1 correspond to the input model 
data: 1) experiment number, 2) childhood asthma 
prevalence reported in the bibliography P(D), 3) OR 
smoking risk of asthma by smoking parents, 4) parental 
smoking prevalence (%) P(F). They also include the 
output model data: 6) total childhood prevalence of 
asthma 0-11 years (%) (CI95%), 7) prevalence of 
childhood asthma for Phenotype 1 incidence, 8) 
prevalence of childhood asthma for Phenotype 2, 9) 
prevalence of childhood asthma for Phenotype 3, and 
10) empirical P(D)?, P(F)? , P(D/F)?, P(D/NF)?  , which were 
estimated using the multivariate function Z1 (Figure 2). 
The results of the simulated prevalence of asthma, 
presented in Table 1, are summarised in Figure 4 
where the different values of real smoking prevalence 
(X) are represented in comparison to the asthma 
prevalence obtained by simulation (Y) for OR=1.4 and 
OR=2. The fitted curves using a third order inverse 
polynomial model and R2 were also calculated and the 
equation of the adjusted regression curve was: 
OR 2:  
 
y = 15.2575+ (
-222.1351
x
) + (
5009.4508
x2
) + (
-33225.4999
x3
) , 
R2 = 0.9600, Adj R2 =0.9199 
OR 1.4:  
 
y ' = 8.2776 + (
326.1495
x
) + (
-3847.7113
x2
) + (
7096.1329
x3
) ,  
R2 = 0.9981, Adj R2=0.9961 
Where 
 
f (x) =% asthma prevalence, x = % smoking 
prevalence. 
As shown in Figure 5 and the results obtained in 
Table 1, the prevalence of asthma obtained by 
simulation varied from 14.5-16% for OR=2 and 12-13% 
for OR=1.4. Thus, the prevalence of asthma increased 
or there was a random, consistent trend between 1997 
and 2007 for the curve OR = 2 and OR = 1.4, as
 
Figure 3: Childhood asthma DES model which takes into account the prevalence and phenotypes (D is the asthma event, F is 
the tobacco risk factor, OR is the odds ratio of asthma related to smoking, 
 
t
1
, t
2
, t
3
 are random variables with a Weibull 
distribution, used to generate wheezing episodes as a function of parents' smoking prevalence). 
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Table 1: Table of Results of the Simulated Prevalence of Asthma (%) and the Phenotypes Obtained. The Simulations 
were Performed Using Two Odds Ratio (OR) Risks of Tobacco in Asthma and with Different Levels of 
Tobacco Prevalence 
 Simulation Model input Simulation Model output (n=10000) 
Experiment 
number 
P(D) 
Childhood 
asthma 
prevalence 
reported on 
the 
bibliography 
(%) 
OR 
Smoking 
risk of 
asthma by 
smoking 
parents  
P(F) 
Parents 
Smoking 
Prevalence 
(%) 
Total** 
childhood 
asthma 
prevalence 
0-11 years 
(%) (CI95%) 
Childhood 
asthma 
prevalence 
phenotype 1 
0-11 years 
(%)(CI95%) 
childhood 
asthma 
prevalence  
Phenotype 2 
prevalence 
0-11 years 
(%)(CI95%) 
childhood 
asthma 
prevalence  
Phenotype 3 
0-11 years 
(%)(CI95%) 
Empirical 
P(D) 
P(F) 
P(D/F) 
P(D/NF) 
1 10-17% 2 
32.9%  
prevalence 
1997, 1999 
14.8664000 
14.7922016 
14.9405984 
80.2604000 
(80.1731963 
80.3476037) 
14.7068200  
 (14.6275994 
14.7860406) 
 5.0325200 
(4.9854013 
5.0796387) 
0.1049243 
 0.3279227 
 0.1517241 
 0.08208955 
2 10-17% 1.4 
32.9% 
prevalence 
1997, 1999 
12.2533000 
12.1887330 
12.3178670  
80.2544800 
(80.1461306 
80.3628294) 
14.7143000  
(14.6199388 
14.8086612) 
 5.0315400 
(4.9738622 
5.0892178) 
0.1040040 
 0.3331247 
 0.1257282 
 0.09315213 
3 10-17% 2 
35.1% 
prevalence 
2001 
14.6381000 
14.5628906 
14.7133094 
80.2586000 
(80.1715261 
80.3456739) 
14.7322200  
 (14.6537057 
14.8107343) 
5.0091200 
(4.9586265 
5.0596135) 
0.1049896 
 0.3493851 
 0.1497660 
 0.08094435 
4 10-17% 1.4 
35.1% 
prevalence 
2001 
12.2725000 
12.1991160 
12.3458840 
80.1861800 
(80.1020928 
80.2702672) 
14.7852600  
(14.7101304 
14.8603896) 
5.0285400 
(4.9805308 
5.076549) 
0.1047866 
 0.3535106 
 0.1258675 
 0.09325916 
5 10-17% 2 
26.4%  
prevalence 
2006 
15.4003000 
(15.3361803 
15.4644197) 
80.3333400 
(80.2278108 
80.4388692) 
14.6459400  
(14.5515387 
14.7403413) 
5.0207400 
(4.9621523 
5.0793277) 
0.1047066  
 0.2660397  
 0.1575934  
 0.08553670  
6 10-17% 1.4 
26.4%  
prevalence 
2006 
11.9877000 
(11.9143380 
12.0610620) 
80.2341283 
(80.1274635 
80.3407930) 
14.7420641  
 (14.6456656 
14.8384626) 
5.0239880 
(4.9663729 
5.0816031) 
0.9923984  
 0.2638768  
 0.1227028  
 0.09082912  
7 10-17% 2 
23.7%  
prevalence 
2006 
15.6267000 
(15.5579346 
15.6954654) 
79.94940000 
(79.75834152, 
80.14045848) 
15.05670000 
(14.88043750, 
15.23296250) 
4.99380000 
(4.89542291, 
5.09217709) 
0.1047527  
 0.2397281  
 0.1604146  
 0.08720147  
8 10-17% 1.4 
23.7% 
Prevalencia 
2007 
 12.6848485 
(12.6235559 
12.7461411) 
80.2447400 
(80.1373015 
80.3521785) 
14.7633200  
 (14.6648187 
14.8618213) 
4.9916200 
(4.9365465 
5.0466935) 
0.1040497  
 0.2368210  
 0.1295909  
 0.09612403  
9 10-17% 2 20% 
16.0384000 
(15.9646385 
16.1121615) 
80.2400400 
(80.1541019 
80.325978) 
14.7108800 
(14.6346332 
14.7871268) 
5.0490200 
(4.9994502 
5.0985898) 
0.1042693  
 0.1999759  
 0.1640169  
 0.08933464  
10 10-17% 1.4 20% 
12.3386000 
(12.2701895 
12.4070105) 
80.2765800  
 (80.1725637 
80.3805963) 
14.7477600  
 (14.6600040 
14.8355160) 
4.9761000 
4.9208583 
5.0313417 
0.1003084  
 0.2046071  
 0.1263299  
 0.09361460  
11 10-17% 
2 
(Lower OR 
95 IC limit) 
15% 
 14.9664000 
(14.8969713 
15.0358287) 
80.3354600 
(80.2435757 
80.4273443) 
14.6704800  
(14.5858819 
14.7550781) 
4.9940400 
(4.9425785 
5.0455015) 
0.1036956  
 0.1528018  
 0.1685081  
 0.09200589  
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(Table 1). Continued.  
 Simulation Model input Simulation Model output (n=10000) 
Experiment 
number 
P(D) 
Childhood 
asthma 
prevalence 
reported on 
the 
bibliography 
(%) 
OR 
Smoking 
risk of 
asthma by 
smoking 
parents  
P(F) 
Parents 
Smoking 
Prevalence 
(%) 
Total** 
childhood 
asthma 
prevalence 
0-11 years 
(%) (CI95%) 
Childhood 
asthma 
prevalence 
phenotype 1 
0-11 years 
(%)(CI95%) 
childhood 
asthma 
prevalence  
Phenotype 2 
prevalence 
0-11 years 
(%)(CI95%) 
childhood 
asthma 
prevalence  
Phenotype 3 
0-11 years 
(%)(CI95%) 
Empirical 
P(D) 
P(F) 
P(D/F) 
P(D/NF) 
12 10% 
1.4 
(Lower OR 
95 IC limit) 
15% 
12.8976000 
(12.8302569 
12.9649431) 
80.3534600 
(80.2433009 
80.4636191) 
14.6723400  
(14.5725473 
14.7721327) 
4.9741600 
(4.9152548 
5.0330652) 
0.1033003  
 0.1509414  
 0.1322289  
 0.09815756  
13 10% 
2 
(Lower OR 
95 IC limit) 
10% 
9.5160000 
(9.4611450 
9.5708550) 
80.2790200 
(80.1608839 
80.3971561) 
14.7079000  
 (14.6029393 
14.8128607) 
5.0130800 
(4.9543184 
5.0718416) 
0.1045221  
 0.09790911  
 0.1763846  
 0.09672246  
14 10% 
1.4 
(Lower OR 
95 IC limit) 
10% 
9.9114000 
(9.8464339 
9.9763661) 
80.2997200 
(80.1916846 
80.4077554) 
14.6838800  
 (14.5894992 
14.7782608) 
5.0166800 
(4.9562056 
5.0771544) 
0.1043403 
 0.09915015 
 0.1357572 
 0.1008825 
 
 
Figure 4: Results of the simulated prevalence of asthma (%) 
for n=10000 cases, obtained for different levels of tobacco 
prevalence in Spain (1997, 2001, 2006, 2007 and 20%, 15% 
and 10%). The simulations were performed using two odds 
ratio (OR) risks of tobacco in asthma. The Gaussian 95% 
confidence intervals for the mean prevalence of the 100 
simulation replications are also represented, however they 
are the minimum observed due to the low dispersion. The 
fitted curves as a third order inverse polynomial model and 
the R2 are represented. 
reflected in the bibliography. This occurred despite the 
decrease in the prevalence of tobacco from 32.9% in 
1997 to 35.1% in 2001 and 23.7% in 2007. No clear 
drops in the prevalence of asthma and the prevalence 
of tobacco were observed for 20% OR = 2, or 15% OR 
= 1.4. However, there were lower values for 10% 
prevalence of tobacco. 
 
Figure 5: Histogram frequency of different episodes of 
wheezing in the simulation model of childhood asthma built in 
this work. The time horizon is 11 years. Histogram of 
phenotype asthma episodes (wheezing). 
The curves adjusted to the simulation values show 
that the slope was negative from a lower prevalence of 
20% for OR = 2 and a 15% prevalence for the curve 
OR = 1.4. 
The distribution of phenotypes of simulated asthma 
conforms perfectly with the model 80%:15%:5% in the 
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literature, as shown in Table 1, which also indicates the 
confidence interval of 95%. 
The sub-distribution of asthma phenotypes and the 
distribution of wheezing events were not studied. 
However, they may be useful in a future improved 
model, in which the prevalence of tobacco for each 
different phenotype could be considered, or the effect 
of tobacco on wheezing events. 
4. DISCUSSION 
Childhood asthma is genetically determined, but 
factors that make some individuals develop asthma 
early are currently the subject of research. 
Environmental causes are important risk factors for 
asthma. It is important to discover these causes, in 
order to reduce the prevalence and incidence of 
asthma, which are currently increasing. 
No statistical or simulation models exist to forecast 
the evolution of childhood asthma in Europe. There are 
formal methods for constructing simulation models in 
an epidemiologic framework and methods to assure 
that these models are credible. These models basically 
follow validation, verification and accreditation phases 
[27]. During the experimental phase, the models are 
executed (run over time) in order to generate results. 
The results can then be used to provide an insight into 
the system and as a basis for decision-making. Such 
models need to incorporate the main risk factors that 
can be managed by medical authorities, such as 
tobacco (OR asthma diagnosis = 1.44, 2), to establish 
how they affect the present generation of children. 
Thus, the number of cases can be forecast from an 
epidemiological perspective, as can their possible 
treatment, and whether to assign more or less public 
resources to asthma treatment. 
To investigate the relationship between ETS 
exposure and childhood asthma more thoroughly, a 
meta-analysis of studies purporting to examine this 
issue was undertaken by the US Department of Health 
and Human Services [10]. A Medline search was 
conducted to identify all epidemiologic studies 
published between 1975 and 1995 examining ETS 
exposure as a risk factor for the induction of childhood 
asthma. Of the 37 studies included in this analysis, all 
but three reported a risk ratio (RR) greater than 1.0, 
although many were not statistically significant at ? = 
0.05. The pooled RR for those studies with clinically 
diagnosed asthma as the outcome was 1.44 (95% CI = 
1.27-1.64). This study concludes that ETS increased 
the risk of asthma (OR =1.44 (95% CI 1.27-1.64) [11]. 
Other studies [28] hypothesized that the joint effect 
of genetic propensity to asthma and exposure to ETS 
on the risk of childhood asthma was greater than 
expected on the basis of their independent effects and 
constituted an important risk factor for this disease. A 
population-based 4-year cohort study of 2,531 children 
born in Oslo, Norway was analyzed. Information on the 
child's health and environmental exposure at birth and 
when the child was 6, 12, 18, and 24 months as well as 
4 years of age was collected. The outcomes of interest 
were bronchial obstruction during the first 2 years and 
asthma at the age of 4 years. The study found in a 
logistic regression analysis adjusted for confounding 
that parental atopy alone increased the risk of bronchial 
obstruction (OR 1.62; 95% confidence interval [CI] 
1.10-2.40) and asthma (1.66; 95% CI, 1.08-2.54). The 
results are consistent with the hypothesized joint effect 
of parental atopy and exposure to ETS. This 
phenomenon, denoted as effect modification of 
environmental exposure by genetic constitution or gene 
by environment interaction, suggests that some genetic 
markers could indicate susceptibility to environmental 
factors. 
Finally, other epidemiological studies concluded that 
involuntary smoke exposure was associated with 
increased asthma severity and worsened lung function 
in a nationally representative group of US children with 
asthma. Asthmatic children with high levels of smoke 
exposure, compared with those with low levels of 
exposure, were more likely to have moderate or severe 
asthma (OR, 2.7 95% confidence interval [CI], 1.1 to 
6.8) and decreased lung function, with a mean FEV1 
decrement of 213 mL or 8.1% (95% CI, -14.7 to -3.5) 
[29]. 
The model presented here includes the main risk 
factor affecting asthma (tobacco), so as to be able to 
forecast the likelihood of the illness in the future as a 
function of the risk factors and how these factors 
change. Parameters of the model (input) data were 
taken from the bibliography along with data from a 
panel of experts from a hospital in Barcelona. 
The DES was used to construct the simulation 
model. A simulation model for childhood asthma has 
been validated with respect to those validated in the 
bibliography. The preliminary result (10,000 simulated 
cases) for the scenario enabled the behaviour of the 
prevalence and phenotypes of childhood asthma to be 
observed. 
The reduction of 5-10% of smokers in Spain (from 
35.2% in 2001 to 23.7% in 2007) did not have a 
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significant effect on reducing the prevalence of 
childhood asthma in the following years. The 
simulations established a threshold for a notable 
reduction in the prevalence of asthma between 15 and 
20% of smokers. 
The prevalence of asthma obtained using a 
probabilistic simulation varied from 14.5-16% for OR=2 
and 12-13% for OR=1.4. Asthma prevalence values 
increased or there was a random, consistent trend from 
1997 to 2007, both for the curve OR = 2 and OR = 1.4, 
as reflected in the bibliography, despite the decrease in 
the prevalence of tobacco from 32.9% in 1997 to 
35.1% in 2001 and 23.7% in 2007. No clear drops in 
asthma prevalence according to tobacco prevelance 
were observed for 20% OR = 2, or 15% OR = 1.4. 
However, they were observed at values under 10% 
prevalence of tobacco. The curves adjusted to the 
simulated values showed a negative slope for a lower 
prevalence of 20% for OR = 2 and 15% for the curve 
OR = 1.4. 
This study adds a simulation methodology including 
modifiable asthma risk factors, in order to be applied to 
significantly reduce the number of cases. Once 
completed, this simulation methodology can realistically 
be used to forecast the evolution of childhood asthma 
as a function of variation in different risk factors. 
This simulation model, once completed, validated 
and adjusted, can be used to forecast the evolution of 
childhood asthma as a function of the variation in 
different risk factors. The model also deals with 
problems associated with risk factors in the field of 
epidemiology. Fluctuations in probabilities over time 
can be assessed in large populations. 
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